Anne Charlotte Ackermann

All Articles

A new “flat-rate payment” system may likely be very common for upcoming orphan medicines in France.

As we start 2022, the global market access environment has reached an unprecedented high level of risk.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive.

A weekly roundup of the latest news and analysis, sent every Friday.

The pharmaceutical industry's most comprehensive news and information delivered every month.

I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy

SUBSCRIBED

Thank you for subscribing to Pharmaceutical Technology

THANK YOU